Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) Director Esteban Lopez sold 250 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $93.00, for a total transaction of $23,250.00. Following the transaction, the director directly owned 3,450 shares in the company, valued at approximately $320,850. The trade was a 6.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.
Esteban Lopez also recently made the following trade(s):
- On Thursday, May 21st, Esteban Lopez sold 250 shares of Addus HomeCare stock. The shares were sold at an average price of $93.00, for a total transaction of $23,250.00.
Addus HomeCare Stock Down 0.7%
Shares of Addus HomeCare stock opened at $92.65 on Friday. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The company’s fifty day simple moving average is $95.72 and its two-hundred day simple moving average is $105.47. The company has a market cap of $1.73 billion, a P/E ratio of 17.13, a PEG ratio of 1.27 and a beta of 0.92. Addus HomeCare Corporation has a 12-month low of $89.76 and a 12-month high of $124.43.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. Stephens reduced their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Barclays reduced their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.22.
Read Our Latest Research Report on ADUS
Institutional Trading of Addus HomeCare
Hedge funds and other institutional investors have recently modified their holdings of the business. Global Retirement Partners LLC grew its position in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the period. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare in the 4th quarter worth about $29,000. Arax Advisory Partners boosted its stake in Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares in the last quarter. Finally, Private Trust Co. NA boosted its stake in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
